Compare SYM & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SYM | ITGR |
|---|---|---|
| Founded | 2005 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 4.3B |
| IPO Year | 2021 | 2000 |
| Metric | SYM | ITGR |
|---|---|---|
| Price | $38.69 | $126.70 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 17 | 9 |
| Target Price | $62.86 | ★ $121.80 |
| AVG Volume (30 Days) | ★ 1.5M | 678.5K |
| Earning Date | 11-23-2026 | 10-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.12 | ★ 1.17 |
| Revenue | ★ $2,246,922,000.00 | $1,853,637,000.00 |
| Revenue This Year | $24.68 | N/A |
| Revenue Next Year | $29.41 | $5.96 |
| P/E Ratio | $331.42 | ★ $108.32 |
| Revenue Growth | ★ 25.65 | 7.98 |
| 52 Week Low | $36.47 | $62.00 |
| 52 Week High | $87.88 | $126.80 |
| Indicator | SYM | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 40.10 | 72.72 |
| Support Level | N/A | $126.16 |
| Resistance Level | $44.66 | $126.80 |
| Average True Range (ATR) | 1.77 | 0.13 |
| MACD | -0.53 | -0.21 |
| Stochastic Oscillator | 28.67 | 79.41 |
Symbotic Inc. is an automation technology company that develops solutions to improve operating efficiencies in modern warehouses. The group designs, commercializes, and deploys end-to-end technology systems that significantly enhance supply chain operations. The company automates the processing of pallets, cases, and individual items within warehouse environments. Its systems strengthen operations at the front end of the supply chain and provide benefits to all supply partners downstream. The company operates in two geographical regions: the United States and international markets, with the majority of its revenue generated in the United States.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.